:
4
|
|
143. Heineman M., Thomas C, Doesburg W. et al. Pituitary and ovarian responses to LHRH stimulation in women with clinical features in the polycystic ovary syndrome // Europ. J. Gynecol. Reprod. Biol. 1984. Vol. 17. P. 273-284.
144. Hodges L. C, Hunter D. S., BergersonJ. S. et al. An in-vivo/in-vitro model to assess disrupting activity of xenoestrogens in uterine leiomyoma//Ann. NY Acad. Sci. 2001. Vol. 948. P. 100-111.
145. Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? // J. En-docrin. Invest. 1998. Vol. 21. 9. P. 589-601.
146. Homburg R., Amsterdam A. Polycystic ovary syndrome loss of the apoptotic mechanism in the ovarian follicles? // J. Endocrin. Invest. 1998. Vol. 21. 9. P. 552-557.
147. Hooghe Th., Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and baboons // Hum. Reprod. Update. 2000. Vol. 8. 1. P. 84-88.
148. Insler V., Shoham Z., Barash A. et al. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings // Hum. Reprod. 1993. Vol. 8. 8. P. 379-384.
149. International Histological Classification of Tumors 13. Geneva: World Health Organization, 1975. 68 p.
150. Ismail M. S., Serour G. I. Torsten U. et al. Elevated serum prolactin level with high-dose estrogen contraceptive pills // Europ. J. Contra-cept. Reprod. Health Care. 1998. Vol. 3. 1. P. 45-50.
151. Jacobson T. Z., Barlow D. H., Garry R. et al. Laparoscopic surgery for pelvic pain associated with endometriosis (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 2003.
152. Khurana K. K., Singh S. ., Tatum A. H. et al. Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy // J. Reprod. Med. Vol. 44. 6. P. 487-492.
153. Kidson W. Polycystic ovary syndrome: a new direction in treatment // Med. J. Aust. 1998. Vol. 169. 10. P. 537-540.
154. Kitawaki /., Kado K, Ishihara H. et al. Endometrioses: the pathophysiology as an estrogen-dependent disease // J. Steroid Biochem. Mol. Biol. 2003. Vol. 1790. P. 1-7.
155. Koh Ch. H., Janik Gr. M. The surgical management of deep rectovaginal endometriosis // Curr. Opin. Obstet. Gynecol. 2002. Vol. 14. 4. P. 357-364.
156. Koivunen R., Laatkainen ., Tomas et al. The prevalence of polycystic ovaries in healthy women // Acta Obstet. Gynecol. Scand. 1999. Vol. 78. P. 137-141.
157. Kopitovic V., Sujas M., Fistas Topalski N. et al. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients // Med. Pflegl. 2001. Vol. 54. 7-8. P. 339-346.
158. Kostal M., Tosner J. The influence of latent hyperprolactinaemia on the levels of LH, FSH, E2 and T in the midfollicular phase of the cycle // Arch. Gynec. Obstet. 1997. Vol. 259. 2. P. 65-68.
159. Lebovic D. I., Mueller M. D., Taylor R. N. Immunobiology of endometriosis // Fertil. and Steril. 2001. Vol. 75. 1. P. 1-9.
160. Legro R. S. The genetics of obesity. Lessons for polycystic ovary syndrome // Ann. NY Acad. Sci. 2000. Vol. 900. P. 193-202.
4.
161. Legro R. S., Kunselman A. R., Dodson W. . et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women // J. clin. Endocr. 1999. Vol. 84. 1. P. 165-169.
162. Lessey B. Medical management of endometriosis and infertility// Fertil. and Steril. 2000. Vol. 73. 6. P. 1089-1096.
163. LethabyA., Vollenhoven ., SowterM. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids // Cochrane Database Syst. Rev. 2000. Vol. 2. CD000547.
164. Lumbiganon P., Rugpao S., Phandufung S. et al. Protective effect of depot-medoxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case control study // Brit. J. Obstet. Gynecol. 1995. Vol. 103. P. 909-914.
165. Maheux R., Guilloteau C, Lemay A. et al. Regression of leiomyo-mata uteri following hypooestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report // Fertil. and Steril. 1984. Vol. 42. P. 644-646.
166. Maheux R., Lemay A., Blanchet P. et al. Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing releasing hormone agonist implant: a pilot study// Hum. Reprod. 1990. Vol. 6. 4. P. 500-505.
167. Marshall L. M., Spiegelman D., Manson J. E. et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking // Epidemiology. 1998. Vol. 9. 5. P. 511-517.
168. Matalliotakis I. M., Goumenou A. G., Koumantakis G. E. et al. Expression of serum human leukocyte antigen and growth factor levels in a Greek family with familial endometriosis // J. Soc. Gynec. Invest. 2003. Vol. 10. 2. P. 118-121.
169. Matalliotakis I. M., Goumenou A. G., Koumantakis G. E. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines // International Immunopharmacology. 2003. Vol. 3. P. 8189.
170. Matsumoto Y., Iwasaka ., Yamasaki F. et al. Apoptosis and Ki-67 expression in adenomyotic lesions and the corresponding eutopic endometrium // Obstet. and Gynec. 1999. Vol. 94. 1. P. 71-77.
171. Matsuo H., Kurachi ., Shimomura Y. etal. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis on human uterine leiomyoma // Oncology. 1999. Vol. 57. Suppl. 2. P. 49-58.
172. Matta W. K, Stabile I., Shaw R. W. et al. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the go-nadotropin-releasing hormone agonist Buserelin // Fertil. and Ster-il. 1988. Vol. 49. 6. P. 1083-1085.
173. McCluggage W. G, Ellis P. K., McClure N. etal. Pathologic futures of uterine leiomyomas following uterine artery embolization // Int. J. Gynec. Pathol. 2000. Vol. 19. 4. P. 342-347.
174. Metka M., Holzer G., Raimann H. et al. The role of prolactin in the menopause // Maturitas. 1994. Vol. 2-3. P. 151-154.
175. Moen M. H., Magnus P. The familial risk of endometriosis //Acta Obstet. Gynecol. Scand. 1993. Vol. 72. 7. P. 560-564.
176. Moen M. N., Stokstad Tr. A long-term follow-up study of women with asymptomatic endometriosis diagnosed incidentally at sterilization // Fertil. and Steril. 2002. Vol. 78. 4. P. 773-776.
177. Moore J., Copley S., Morris J. et al. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis // Ultrasound Obstet. Gynecol. 2002. Vol. 20. P. 630-534.
178. Moore J., Kennedy S., Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
179. Morton . . Many tumors and many genes. Genetics of uterine leiomyomata//Amer. J. Pathology. 1998. Vol. 153. 4. P. 1015-1020.
180. New concepts in the diagnosis and treatment of genital endometriosis / Ed. by L. Mettler. Lancaster: Parphenon Publ. Group, 1988. 68 p.
181. Nisolle M., Casanos-Roux F., Ana/ V. et al. Morphometric study of the stromal vascularization in peritoneal endometriosis // Fertil. and Steril. 1993. Vol. 59. 3. P. 681-684.
182. Nisolle M., DonnezJ- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities // Fertil. and Steril. 1997. Vol. 68. 4. P. 585-596.
183. NisolleM., GillerotS., Casanas-RouxF. etal. Immunohistochemi-cal study of the proliferative index, estrogen receptors A and in
2 1 . M. 625
4.
leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy // Hum. Reprod. 1999. Vol. 14. 11. P. 2844-2850.
184. Norman R. J., Moran L., Davies M. J. Nutritional aspects of polycystic ovary syndrome // Reprod. Med. Review. 2001. Vol. 9. 2. P. 91-107.
185. Olive D. L., Henderson D. V. Endometriosis and mullerian anomalies // Obstet. Gynecol. 1987. Vol. 69. 3. P. 412-415.
186. Pedwine D. Is " microscopic" peritoneal endometriosis invisible? // Fertil. and Steril. 1988. Vol. 50. 3. P. 665-666.
187. Prentice A., Deary A. J., Goldbeck-Wood S. et al. Gonadotropin-realising hormone analogues for pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
188. Redigor P. A., Regidor M., Schmidt M. et al. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrol in the treatment of severe endometriosis // Gynec. Endocrinol. 2001. Vol. 15. 3. P. 202-209.
189. Redwine D. ., Wright J. T. Laparoscopic treatment of complete obliteration of the cul-de-sac associated with endometriosis: long-term follow-up // Fertil. and Steril. 2001. Vol. 76. 4. P. 358-365.
190. Reese K. A., Reddy S., Rock J. A. Endometriosis in an adolescent population: the Emory experience //J. Pediatr. Adolesc. Gynecol. 1996. Vol. 9. 3. P. 125-128.
191. Rier S., Foster W. G. Environmental dioxins and endometriosis // Semin. Reprod. Med. 2003. Vol. 21. 2. P. 145-154.
192. Sampson J. A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity // Amer. J. Obstet. Gynecol. 1927. Vol. 14. P. 422-469.
193. Sato F., Miyake H., Nishi M. et al. Fertility and uterine size among Asian women undergoing hysterectomy for leiomyomas // Int. J. Fertil. Women's Med. 2000. Vol. 45. 1. P. 34-37.
194. SattarN., Hopkinson Z., Green J. Insulin-sensitising agents in poly-cystic-ovary syndrome // Lancet. 1998. Vol. 351. P. 305-307.
195. Scialli A. R., Levi A. J. Intermittent leuprolide acetate for nonsurgical management of women with leiomyomata uteri // Fertil. and Steril. 2000. Vol. 74. 3. P. 540-546.
196. Selak V., Farguar C, Prentice A. et al. Danazol for pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
197. Seminara S. R., Crowley W. F. Genetic approaches to unravelling reproductive disorders: examples of bedside to bench research in the genomic era // Endocrine Reviews. 2002. Vol. 23. 3. P. 382-392.
198. Seracchioli R., Rossi S., Govoni F. et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myoma: a randomized comparison with abdominal myomectomy // Hum. Reprod. 2000. Vol. 15. 12. P. 2663-2668.
199. Shaw R. W. Gonadotropin hormone-releasing hormone analogue treatment of fibroids // Baillier's Clin. Obstet. Gynaecol. 1998. Vol. 12. 2. P. 245-267.
200. Simpson J. L. The Watteville Memorial Lecture: Reproductive technologies and genetic advances in obstetrics and gynecology // Int. J. Gynec. Obstet. 1992. Vol. 38. P. 261-280.
201. Simpson J. L., Elias S., Malinak et al. Heritable aspects of Endometriosis // Amer. J. Obstet. Gynecol. 1980. Vol. 137. 3. P. 327-331.
202. Takanashi K., Kawamura N., Ishiko O. et al. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12; 14) // Int. J. Oncol. 2002. Vol. 20. 2. P. 279-283.
203. Teirney R., Prentict A. The medical management of endometriosis // Rev. in Gynec. Practice. 2002. Vol. 2. P. 91-98.
204. Testa G., Vegetti W., Motta T. et al. Two-year treatment with oral contraceptives in hyperprolactinemic patients // Contraception. 1998. Vol. 5. 2. P. 69-73.
205. Valle R. F. Endometriosis: current concepts and therapy // Int. J. Gynec. Obstet. 2002. Vol. 78. P. 107-119.
206. Vankova M., Vbrikova J., Hill M. et al. Association of insulin gene VNTR polymorphism with polycystic ovary, syndrome // Ann. NY Acad. Sci. 2002. Vol. 967. P. 558-565.
207. Velardo A., Toshi E., Pantaleoni M. et al. Heyperprolactinaemia nell'ipotiroidismo: effetti della terapia con L-tiroxina // Minerva Endocrinol. 1994. Vol. 19. 1. P. 1-4.
208. Vercellini P., Aimi G., Panazza St. Deep endometriosis conundrum: evidence in favor of a peritoneal origin // Fertil. and Steril. 2000. Vol. 73. 5. P. 1043-1046.
2i* 627
4.
209. Vercellini P., Cortesi L, Crosignani P. G. Progestins for symptomatic endometriosis: a critical analysis the evidence // Fertil. and Steril. 1997. Vol. 68. 3. P. 393-401.
210. Vercellini P., Zaina ., Yaylayan L. et al. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility // Obstet. and Gynec. 1999. Vol. 94. 3. P. 341-347.
211. Vignali M., Infantino M., Matrone R. et al. Endometriosis: ethio-pathogenetic concepts and clinical perspectives // Fertil. and Steril. 2002. Vol. 78. 4. P. 665-678.
212. Vikhlyaeva E. V., Khodzhaeva Z. S., Fantschenko N. D. Familial predisposition to uterine leiomyomas // Int. J. Gynec. Obstet. 1995. Vol. 51. 2. P. 127-132.
213. Vinatier D., Cosson M., Dufour P. Is endometriosis an endometrial disease? // Europ. J. Obstet. Gynecol. 2000. Vol. 91. 2. P. 113-125.
214. Vollenhoven B. J. Conclusion // Bailliere's Clin. Obstet. Gynecol. 1998. Vol. XX. 2. P. 337-340.
215. Walter A. J., Hentz J- G., Magtibay P. M. et al. Endometriosis: Correlation between histologic and visual findings at laparoscopy // Obstet. and Gynec. 2001. Vol. 184. P. 1407-1413.
216. Wang H., Jin J. Effects of mifepriston on estrogen and progestin receptors in human uterine leiomyoma // Zhonghua Fu Chan Ke Za Zhi. 2000. Vol. 35. 2. P. 4476-4481 ( no Pub Med ID: 11809103).
217. Wang Y., Matsuo H., Kurachi O. et al. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells // Europ. J. Endocrinol. 2002. Vol. 146. 3. P. 447-456.
218. Weyl S., Daniel J., Vogel W. Interet de l'hysteroscopie operatoire dans le traitment des myomas et polypes fibreaux intracavitaires // J. Gynec. Obstet. Biol. Reprod. 1985. Vol. 14. P. 1045-1048.
219. Wichljaeva E. M., Fantschenko N. D., Saporoshan V. N. 1st die Kry-ochirurgie als alternatives Heilverfahren fur eine rezidivierende Hy-perplasie des Endometriums wahrend der Perimenopause zu betra-chten? // Zbl. Gynakologie. 1985. Bd. 107. S. 869-877.
220. Wild R. A. Long-term health consequences of PCOS // Hum. Re-prod. Update. 2002. Vol. 8. 3. P. 231-241.
221. WuX., BlanckA., OlovssonM. et al. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause // Acta Obstet. Gynecol. Scand. 2000. Vol. 79. 5. P. 397-404.
222. Zaidi J., Jacobs H., Campbell S. et al. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations // Ultrasound Obstet. Gynecol. 1998. Vol. 12. 3. P. 188-196.
5